U.S. FDA has granted Orphan Drug Designation to SPG601 for the Treatment of Fragile X Syndrome SPG601 is a novel…
Experienced commercial leader takes helm to expand cardiovascular diagnostic company globally and commercialize company’s flagship plaque analysis softwareBOSTON--(BUSINESS WIRE)--Elucid, a…
– 43% of Participants Showed Improvement on the UMSARS Activities of Daily Living Scale – – 29% of Participants had…
– 43% of Participants Showed Improvement on the UMSARS Activities of Daily Living Scale – – 29% of Participants had…
LOS ANGELES, July 16, 2024 (GLOBE NEWSWIRE) -- Trethera Corporation, a clinical stage biopharmaceutical company committed to developing novel drugs…
PARSIPPANY, N.J., July 15, 2024 /PRNewswire/ -- Med-Metrix, LLC ("Med-Metrix", or the "Company"), a leading provider of technology-enabled, Revenue Cycle…
First of its Kind Initiative to Guide Future Improvements in Data Collection, Management, and Utilization to Enhance Efficiencies and Improve…
Game-changing PayParity® tool optimizes salary adjustments tomaximize ROI and impact on employees LOS ANGELES, July 10, 2024 /PRNewswire/ -- Trusaic's…
Findings from preclinical study demonstrate potential for a field and prehospital treatment following a penetrating TBI NEW YORK, July 9,…
HAMILTON, N.J., July 8, 2024 /PRNewswire/ -- Medlogix, LLC, a leading, national medical claims management solutions provider, announced today that…
